Data as of Nov 26
| +0.87 / +0.38%|
The 3 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 300.00, with a high estimate of 325.00 and a low estimate of 292.00. The median estimate represents a +30.41% increase from the last price of 230.05.
The current consensus among 5 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.